The relationship of expression of bcl-2, p53, and proliferating cell nuclear antigen (PCNA) to cell proliferation and apoptosis in renal cell carcinoma

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 24, Issue 4, 2004, Pages 354-357

  Zhu, Zhaohui ^a   Xing, Shian ^a   Cheng, Ping ^a   Li, Guosheng ^a   Yang, Yu ^a   Zeng, Fuqing ^a   Lu, Gongcheng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Bcl 2; P53; Proliferating cell nuclear antigen; Renal cell carcinoma

Indexed keywords

ANTIGENS; GROWTH KINETICS; IMMUNOLOGY; PATHOLOGY; TUMORS;

APOPTOSIS; BCL-2; PF3; PROLIFERATING CELL NUCLEAR ANTIGENS; RENAL CELL CARCINOMA;

CELL CULTURE;

CYCLINE; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; FEMALE; GENETICS; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADULT; AGED; APOPTOSIS; CARCINOMA, RENAL CELL; CELL DIVISION; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 14644428498     PISSN: 0257716X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Onda H, Yasuda M, Serizawa A et al. Clinical outcome in localized renal cell carcinomas related to immunoexpression of proliferating cell nuclear antigen, Ki-67 antigen, and tumor size. Oncol Rep, 1999, 6:1039
2. Levine A J, Momad J, Finlay C A et al. The p53 tumor suppressor gene. Nature, 1991, 351:453
3. Hofmockel G, Wittmann A, Dammrich J et al. Expression of p53, bcl-2 in primary locally confined prognostic renal cell carcinoma: no evidence for prognostic significance. Anticancae Res, 1996, 16:3807
4. Sejima T, Miyagama I. Expression of bcl-2, p53 oncoprotein and proliferating cell nuclear antigen in renal cell carcinoma. Eur Urol, 1999, 35:242
5. Uchida T, Wada C, Schitara T et al. Infrequent involvement of p53 mutation and loss of heterozygosity of 17p in the tumorigenesis of renal cell carcinoma. J Urol, 1993, 150:1298
6. Vasavada S P, Novick A C, Willians B R. p53, bcl-2 and Bax expression in renal cell carcinomas. Urology, 1998, 51:1057
7. Huang A, Fone P D, Gandour-Edwards R et al. Immunohistochemical analysis of bcl-2 protein expression in renal cell carcinomas. J Urol, 1999, 162:610
8. Zhang X H, Takenaka I. Cell proliferation and apoptosis with bcl-2 expression in renal cell carcinoma. Urology, 2000, 56:510